Commonwealth Equity Services LLC Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Commonwealth Equity Services LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3,263.8% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 314,043 shares of the medical instruments supplier’s stock after acquiring an additional 304,707 shares during the period. Commonwealth Equity Services LLC owned approximately 0.16% of DENTSPLY SIRONA worth $5,961,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Cooke & Bieler LP grew its position in DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the period. FMR LLC grew its position in DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after acquiring an additional 436,031 shares during the period. Pacer Advisors Inc. grew its position in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the period. Bank of New York Mellon Corp grew its position in DENTSPLY SIRONA by 27.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock worth $45,611,000 after acquiring an additional 523,692 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock worth $39,880,000 after acquiring an additional 35,360 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.52% of the stock is owned by insiders.

DENTSPLY SIRONA Stock Down 0.3 %

Shares of NASDAQ XRAY opened at $15.56 on Friday. The stock has a market cap of $3.10 billion, a P/E ratio of -7.52, a PEG ratio of 1.80 and a beta of 0.98. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $14.78 and a 12-month high of $33.52. The business’s fifty day simple moving average is $17.92 and its 200-day simple moving average is $20.53.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.11%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on XRAY shares. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Morgan Stanley lowered their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price target for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. UBS Group lowered their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.